Ryan White Care Hepatitis C & B Language
NATAP Webinars:
Friday 12:30pm EST - March 27th, 2026
HIV Treatment Strategies & Prevention; CROI 2026
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
CROI:
bNAb Sensitivity Does Not Fully Explain Post-Treatment Control in Early HIV-Treated Women During ATI
- (03/07/26)
CROI:
Early Switch to CAB+RPV LA in Treatment-Naive Adults With HIV-1: Month 11 Outcomes From VOLITION
- (03/07/26)
CROI:
The role of gut bacteria-specific CD4+ T cells in HIV persistence during ART
- (03/07/26)
CROI:
Decoding the Somatic Mutation Landscape in Persisting HIV-1 Infected CD4+ T Clones
- (03/07/26)
CROI:
CARD8 Activation for Reservoir Reduction with Efavirenz (CARRE Trial) An open-label, single arm trial to assess the safety and efficacy of in vivo CARD8 activation with Efavirenz intensification on HIV-1 reservoir reduction in people living with HIV-1
- (03/07/26)
CROI:
Initiating Semaglutide Therapy Reduces Tobacco Cigarette use among People with HIV
- (03/07/26)
CROI:
The Potential Effect of Ending CDC Funding for HIV Tests: A Modeling Study in 25 US States
- (03/05/26)
CROI:
AUTOLOGOUS NEUTRALISING ANTIBODIES AND EFFECTIVE CD8 T-CELLS MAINTAIN HIV POST-INTERVENTION CONTROL
- (03/05/26)
CROI:
Altered Viral Kinetics at ATI After Dual LS-bNAbs Plus ART: A Preliminary Analysis of RIO Arm B
- (03/05/26)
CROI:
A phase 1 trial of N-803 with or without dual bNAbs to achieve ART-free viral control: ACTG A5386
- (03/05/26)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
CROI:
Efficacy and Safety of Long-Term Bulevirtide in Chronic Hepatitis Delta: Final Results From the Phase 3 MYR301 Study, Including 2 Participants With HIV/HBV/HDV Coinfection
- (02/26/26)
More Hep D Articles...
Aging & Perinatally Acquired HIV
CROI:
HIV can replicate in two cell types in the CNS suggesting multiple pathways to neurologic symptoms
- (03/07/26)
CROI:
Body Mass Index and Virologic Outcomes in Individuals on CAB+RPV LA in the OPERA Cohort
- (03/07/26)
CROI:
Tirzepatide use in People with HIV Shows Effectiveness for Weight Loss and Diabetic Control
- (03/07/26)
CROI:
Real-World Outcomes of Tirzepatide Use in People With HIV With and Without Diabetes
- (03/07/26)
CROI:
Evaluation of GLP-1 Medications in an Observational Cohort of People with HIV in Washington, DC (2011-2025)
- (03/07/26)
CROI:
Effects of Semaglutide on Subclinical Cardiovascular Health in People With HIV
- (03/07/26)
More Aging & HIV Articles...
PrEP
CROI:
Prior PrEP Use and Discontinuation in Individuals Newly Diagnosed with HIV Infection, London, UK
- (03/05/26)
CROI:
Prescriptions for Oral vs Injectable HIV Preexposure Prophylaxis, 2012-2025
- (03/05/26)
CROI:
Declining HIV Incidence and Differential PrEP Effectiveness Among Key Populations With STIs, 2014-25
- (03/02/26)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
CROI:
Simple Adiposity Measures Identify MASLD in People with HIV: Results from a US Multicenter Cohort
- (03/07/26)
CROI:
Effect of DTG/3TC vs. BIC/FTC/TAF on Steatotic Liver Disease: 96-week Analysis of PASO-DOBLE Trial
- (03/07/26)
CROI:
Elevated Triglyceride and Ceramide Metabolites in MASLD among PWH
- (03/07/26)
CROI:
Prevalence and Risk Factors for Steatotic Liver Disease in PWH with Resolved HCV
- (03/07/26)
CROI:
Effect of the TKI Dasatinib in SAMHD1, HIV Reservoir and Senescence in ART-Treated PWH (BCN04-DASA)
- (03/07/26)
CROI:
Point-of-Care HCV RNA Compared to Laboratory-Based HCV RNA in a Tribal Health Setting
- (03/04/26)
CROI:
HIV Status Drives Distinct Immune Pathways of Persistent Portal Hypertension After HCV Cure
- (03/04/26)
CROI:
Baseline Plasma and T-cell Immune Profiles Linked to Liver Stiffness Regression After HCV Cure
- (03/04/26)
CROI:
Glecaprevir/Pibrentasvir Combination Within Individual Particles Drives Optimal LAI Performance
- (03/04/26)
CROI:
Progressing towards global hepatitis C elimination: a systematic review and meta-analysis of care cascades in key populations
- (02/26/26)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
CROI:
VRON-0200 Induced Broad and Sustained Anti-HBV Immunity in Chronically HBV-Infected Patients
- (02/28/26)
AASLD:
Safety, Pharmacokinetics, and Antiviral Activity of the Next-Generation Hepatitis B Capsid Assembly Modulator ABI-4334 in Patients With HBeAg-Negative Chronic Hepatitis B Infection Not Suppressed on Nucleoside Analogues: Results From a Randomized, Blinded, Phase 1b Study
- (12/29/25)
AASLD:
Impact of Baseline HBeAg Status on HBV Outcomes in the ALLIANCE Study
- (11/24/25)
AASLD:
Characterization of HIV/HBV Co-infected Participants Achieving High Rates of Hepatitis B Surface Antigen (HBsAg) Loss in the ALLIANCE Phase 3 Clinical Study
- (11/24/25)
More Hep B Articles...
Fatty Liver, NAFLD, NASH, MASLD, MASH
Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- (02/19/26)
A Phase 2b, Multicenter, Randomized, Placebo- Controlled Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis
- (12/29/25)
Reduction of Liver Fibrosis by Al-Based Digital Pathology Analysis: Results from the Pemvidutide Phase 2b IMPACT Trial
- (12/29/25)
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
- (12/29/25)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
Conference List Here
https://www.croiconference.org/
https://academicmedicaleducation.com/programs/3rd-african-workshop-on-women-and-hiv-2026
https://academicmedicaleducation.com/programs/16th-international-workshop-on-women-and-hiv-2026
https://acthiv.org/
https://ddw.org/?doing_wp_cron=1768748258.8390960693359375000000
https://www.easlcongress.eu/ https://congress-easl.com/
https://asm.org/events/asm-microbe/home
https://academicmedicaleducation.com/programs/24th-european-meeting-on-hiv-and-hepatitis-2026
https://www.iasociety.org/conferences/aids2026
https://academicmedicaleducation.com/programs?page=2
https://academicmedicaleducation.com/programs/27th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-and-other-antiviral-drugs-2026
https://academicmedicaleducation.com/programs/9th-conference-on-liver-disease-in-africa-colda-2026
https://academicmedicaleducation.com/programs/17th-international-workshop-on-aging-and-hiv-2026
https://idweek.org/
https://aasld-igh.org/Home.aspx https://www.aasld.org/the-liver-meeting
https://hivglasgow.org/
